Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Cannabix Technologies (BLOZF) AI Stock Analysis

BLOZF

Cannabix Technologies

(Other OTC:BLOZF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Low LeverageModest leverage reduces solvency pressure and gives the company more financial flexibility than a heavily indebted operation. Although the capital base is weakening, low debt exposure limits interest and refinancing burdens while management develops the company’s technology.
Negative Factors
Minimal Revenue and Persistent LossesThe company has not demonstrated meaningful revenue generation, while losses remain sizable and volatile. This indicates that the operating model has yet to cover its costs, leaving future progress dependent on successful commercialization rather than an established stream of recurring business income.

Cannabix Technologies (BLOZF) vs. SPDR S&P 500 ETF (SPY)

-60%-40%-20%0%20%40%60%BLOZF-29.74%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$37.08M
Dividend Yield
―
Average Volume (3M)
101.51K
Price to Earnings (P/E)
-13.2
Beta (1Y)
-0.22
Revenue Growth
―
EPS Growth
-80.57%
Country
US
Employees
0
Sector
Healthcare
Sector Strength
51
Industry
Other Precious Metals

Cannabix Technologies Business Overview & Revenue Model

Company Description

Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydr...

Cannabix Technologies Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

BLOZF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:VPTTSE:VPT46NeutralCAD 15.43M-6.1356.40%―89.06%37.62%
TSE:PINKTSE:PINK38UnderperformCAD 27.62M-1.41-303.05%―35.27%58.34%

* Healthcare Sector Average

Performance Comparison

0%50%100%150%BLOZFTSE:PINKTSE:VPTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
BLOZF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
BLOZFCannabix0.30-0.08-20.84%
TSE:PINKPerimeter Medical Imaging Ai Inc0.18-0.05-23.40%
TSE:VPTVentriPoint Diagnostics0.08-0.02-20.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.